Coronary occlusion after TAVI in a patient with an anomalous left coronary artery.

Rev Esp Cardiol (Engl Ed)

Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.

Published: December 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rec.2023.06.007DOI Listing

Publication Analysis

Top Keywords

coronary occlusion
4
occlusion tavi
4
tavi patient
4
patient anomalous
4
anomalous left
4
left coronary
4
coronary artery
4
coronary
2
tavi
1
patient
1

Similar Publications

Bypass Grafting for Myocardial Infarction From Endocarditis Embolus to the Left Anterior Descending.

Ann Thorac Surg Short Rep

December 2024

Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.

A 67-year-old man with aortic valve endocarditis presented with acute ST-segment elevation myocardial infarction and was found to have embolic vegetation occlusion of the left anterior descending coronary artery. This patient was successfully treated with early aortic valve replacement, extraction of a vegetation embolus, and coronary artery bypass grafting over the site of extraction.

View Article and Find Full Text PDF

We describe a rare but interesting complication of totally endoscopic robotic mitral valve repair in a patient with severe mitral regurgitation. The mitral valve was repaired robotically by standard techniques, and the intraoperative transesophageal echocardiogram demonstrated no residual mitral regurgitation. However, there was unexpected hypokinesia of the posterior and lateral walls of the left ventricle, with subsequent electrocardiography showing acute ST elevations of the lateral segment.

View Article and Find Full Text PDF

Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions.

Am J Cardiol

January 2025

Cardiology Division, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Baim Institute for Clinical Research, Boston, MA, USA. Electronic address:

There are limited tools available to predict the long-term prognosis of persons with coronary chronic total occlusions (CTO). A previously-described blood biomarker panel to predict cardiovascular (CV) events was evaluated in patients with CTO. From 1251 patients in the CASABLANCA study, 241 participants with a CTO were followed for an average of 4 years for occurrence of major adverse CV events (MACE, CV death, non-fatal myocardial infarction or stroke) and CV death/heart failure (HF) hospitalization.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!